Evolva Holding SA (EVE) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.071x

Based on the latest financial reports, Evolva Holding SA (EVE) has a cash flow conversion efficiency ratio of -0.071x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-440.30K ≈ $-556.66K USD) by net assets (CHF6.24 Million ≈ $7.88 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Evolva Holding SA - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Evolva Holding SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EVE liabilities breakdown for a breakdown of total debt and financial obligations.

Evolva Holding SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Evolva Holding SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mountain Lake Acquisition Corp. Right NASDAQ:MLACR	N/A
Sentra Food Indonesia Tbk PT JK:FOOD	-0.117x
Tri-Mode System M Bhd KLSE:0199	0.023x
SCC Holdings Bhd KLSE:0158	0.099x
Synlogic Inc NASDAQ:SYBX	-0.139x
Vape Holdings Inc NASDAQ:VAPE	-0.091x
Lendway Inc. NASDAQ:LDWY	-0.168x
Atlas Cycles (Haryana) Limited NSE:ATLASCYCLE	0.001x

Annual Cash Flow Conversion Efficiency for Evolva Holding SA (2005–2024)

The table below shows the annual cash flow conversion efficiency of Evolva Holding SA from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see EVE stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF6.60 Million ≈ $8.34 Million	CHF-2.44 Million ≈ $-3.08 Million	-0.370x	+77.81%
2023-12-31	CHF5.55 Million ≈ $7.02 Million	CHF-9.25 Million ≈ $-11.70 Million	-1.667x	-837.83%
2022-12-31	CHF106.24 Million ≈ $134.31 Million	CHF-18.88 Million ≈ $-23.87 Million	-0.178x	+21.39%
2021-12-31	CHF131.77 Million ≈ $166.59 Million	CHF-29.79 Million ≈ $-37.66 Million	-0.226x	-40.40%
2020-12-31	CHF145.09 Million ≈ $183.44 Million	CHF-23.36 Million ≈ $-29.54 Million	-0.161x	-96.22%
2019-12-31	CHF172.56 Million ≈ $218.17 Million	CHF-14.16 Million ≈ $-17.90 Million	-0.082x	+32.51%
2018-12-31	CHF194.16 Million ≈ $245.47 Million	CHF-23.61 Million ≈ $-29.85 Million	-0.122x	+24.56%
2017-12-31	CHF220.72 Million ≈ $279.05 Million	CHF-35.57 Million ≈ $-44.97 Million	-0.161x	+17.61%
2016-12-31	CHF173.06 Million ≈ $218.79 Million	CHF-33.85 Million ≈ $-42.80 Million	-0.196x	-25.41%
2015-12-31	CHF203.42 Million ≈ $257.17 Million	CHF-31.73 Million ≈ $-40.11 Million	-0.156x	-36.86%
2014-12-31	CHF174.99 Million ≈ $221.24 Million	CHF-19.94 Million ≈ $-25.21 Million	-0.114x	+24.21%
2013-12-31	CHF83.28 Million ≈ $105.29 Million	CHF-12.52 Million ≈ $-15.83 Million	-0.150x	+31.51%
2012-12-31	CHF61.24 Million ≈ $77.42 Million	CHF-13.45 Million ≈ $-17.00 Million	-0.220x	+7.62%
2011-12-31	CHF73.22 Million ≈ $92.57 Million	CHF-17.40 Million ≈ $-22.00 Million	-0.238x	+20.48%
2010-12-31	CHF52.97 Million ≈ $66.97 Million	CHF-15.83 Million ≈ $-20.02 Million	-0.299x	-242.18%
2009-12-31	CHF67.93 Million ≈ $85.89 Million	CHF-5.93 Million ≈ $-7.50 Million	-0.087x	+95.71%
2008-12-31	CHF21.86 Million ≈ $27.64 Million	CHF-44.54 Million ≈ $-56.30 Million	-2.037x	-131.41%
2007-12-31	CHF67.12 Million ≈ $84.86 Million	CHF-59.09 Million ≈ $-74.70 Million	-0.880x	-6.84%
2006-12-31	CHF65.48 Million ≈ $82.78 Million	CHF-53.95 Million ≈ $-68.20 Million	-0.824x	-213.41%
2005-12-31	CHF130.88 Million ≈ $165.47 Million	CHF-34.41 Million ≈ $-43.50 Million	-0.263x	--

About Evolva Holding SA

SW:EVE Switzerland Biotechnology

Market Cap

$8.94 Million

CHF7.07 Million CHF

Market Cap Rank

#27655 Global

#210 in Switzerland

Share Price

CHF0.98

Change (1 day)

-4.85%

52-Week Range

CHF0.75 - CHF1.33

All Time High

CHF259.80